Largest Biotechnology Companies By Total Asset

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Total Asset
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Total AssetEfficiencyMarket RiskExp Return
1ABBV AbbVie Inc
134.71 B
(0.07)
 2.09 
(0.14)
2AMGN Amgen Inc
97.15 B
(0.21)
 1.68 
(0.35)
3GILD Gilead Sciences
62.12 B
 0.10 
 1.46 
 0.15 
4GMAB Genmab AS
35.29 B
(0.24)
 1.56 
(0.37)
5HLN Haleon plc
34.05 B
(0.10)
 0.95 
(0.09)
6REGN Regeneron Pharmaceuticals
33.08 B
(0.37)
 1.82 
(0.67)
7BIIB Biogen Inc
26.84 B
(0.32)
 1.38 
(0.43)
8BNTX BioNTech SE
23.01 B
 0.01 
 2.72 
 0.03 
9VRTX Vertex Pharmaceuticals
22.73 B
(0.03)
 1.76 
(0.05)
10GRFS Grifols SA ADR
21.44 B
(0.04)
 3.26 
(0.11)
11MRNA Moderna
18.43 B
(0.23)
 3.43 
(0.79)
12ROIV Roivant Sciences
7.22 B
 0.02 
 1.66 
 0.04 
13UTHR United Therapeutics
7.17 B
 0.02 
 1.86 
 0.04 
14BMRN Biomarin Pharmaceutical
6.84 B
(0.09)
 1.51 
(0.13)
15INCY Incyte
6.78 B
 0.03 
 2.58 
 0.08 
16EXAS EXACT Sciences
6.47 B
(0.04)
 3.87 
(0.16)
17BGNE BeiGene
5.81 B
(0.07)
 2.76 
(0.18)
18ARGX argenx NV ADR
4.54 B
 0.14 
 1.97 
 0.27 
19GLPG Galapagos NV ADR
4.36 B
(0.07)
 2.20 
(0.15)
20GRAL GRAIL, LLC
3.91 B
 0.11 
 5.14 
 0.55 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value. Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY